PSMA
PSMA (27-38) is a synthetic peptide fragment derived from the prostate-specific membrane antigen, a type II transmembrane glycoprotein highly expressed in prostate tissue and various solid tumors. As a defined segment corresponding to amino acid residues 27 through 38 of the PSMA protein, this peptide represents a valuable tool for researchers investigating the structure, function, and biochemical interactions of PSMA in cellular and molecular contexts. Its sequence specificity and structural fidelity allow for targeted studies in fields such as cancer biology, immunology, and peptide-based assay development, making it a critical reagent in both fundamental and applied biochemical research.
Epitope mapping: Researchers frequently use the PSMA (27-38) peptide to delineate antibody binding sites on the PSMA protein. By presenting this defined sequence in immunoassays or ELISA platforms, scientists can determine the specificity and affinity of monoclonal or polyclonal antibodies targeting PSMA, which is essential for the development and validation of immunodetection tools. The precise identification of epitopes facilitates the creation of highly selective reagents for diagnostic and analytical workflows in oncology and molecular pathology.
Protein-protein interaction studies: This peptide fragment serves as a model substrate for investigating the molecular interactions between PSMA and its binding partners. By employing PSMA (27-38) in binding assays, pull-down experiments, or surface plasmon resonance analyses, researchers can dissect the recognition motifs involved in PSMA-mediated signaling or cellular adhesion processes. Such studies are instrumental in elucidating the functional domains of the PSMA protein and understanding its role in tumor progression, angiogenesis, and cell signaling networks.
Peptide-based assay development: The defined sequence of PSMA (27-38) makes it suitable for use as a standard or calibrator in quantitative peptide assays. In mass spectrometry-based proteomics or immunoassay platforms, this peptide can be utilized to optimize detection sensitivity, establish calibration curves, or validate assay specificity. The availability of a high-quality synthetic peptide enables reproducible and accurate quantification of PSMA-derived fragments in complex biological samples, supporting robust analytical workflows in both academic and industrial laboratories.
T-cell epitope analysis: PSMA (27-38) plays a role in immunological research focused on antigen presentation and T-cell recognition. By loading this peptide onto major histocompatibility complex (MHC) molecules in vitro, scientists can assess its ability to activate specific T-cell populations or characterize peptide-MHC binding affinities. Such studies contribute to a deeper understanding of immune surveillance mechanisms and may inform the rational design of immunological assays or research tools for cancer immunology.
Peptide modification and structure-activity studies: The synthetic nature of PSMA (27-38) allows for systematic modification of its amino acid sequence to investigate the impact of structural changes on biological activity. Researchers can introduce specific substitutions, truncations, or chemical modifications to probe structure-activity relationships, stability, or binding properties. This approach provides valuable insights into the functional determinants of PSMA interaction and aids in the rational design of next-generation peptides for research and assay development.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More